Pro: Preoperative autologous blood donation has a role in cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 1, 2003, Pages 121-125

  Karkouti, Keyvan ^a,b   McCluskey, Stuart ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Autologous predonation; Blood; Cost effectiveness

Indexed keywords

ANXIETY; BLOOD DONOR; COST EFFECTIVENESS ANALYSIS; GRAFT VERSUS HOST REACTION; HEART SURGERY; HEMOLYTIC ANEMIA; HUMAN; INFECTION PREVENTION; INFECTION RISK; LUNG INJURY; PATIENT ATTITUDE; PREOPERATIVE CARE; PRIORITY JOURNAL; PURPURA; REVIEW; RISK MANAGEMENT; SAFETY; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0037292945     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2003.23     Document Type: Review

References (35)

1. Brecher ME, Goodnough LT: The rise and fall of preoperative autologous blood donation. Transfusion 41:1459-1462, 2001
2. Etchason J, Petz L, Keeler E, et al: The cost-effectiveness of preoperative autologous blood donations. N Engl J Med 332:719-724, 1995
3. Birkmeyer JD, Goodnough LT, AuBuchon JP, et al: The costeffectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 33:544-551, 1993
4. Birkmeyer JD, AuBuchon JP, Littenberg B, et al: Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 57:161-169, 1994
5. Goodnough LT, Grishaber JE, Birkmeyer JD, et al: Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology 44:226-231, 1994
6. Forgie MA, Wells PS, Laupacis A, et al: Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. Arch Intern Med 158:610-616, 1998
7. Britton LW, Eastlund DT, Dziuban SW, et al: Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg 47:529-532, 1989
8. Kasper SM, Gerlich W, Buzello W: Preoperative red cell production in patients undergoing weekly autologous blood donation. Transfusion 37:1058-1062, 1997
9. Dupuis J-Y, Bart B, Bryson G, Robblee J: Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery. CMAJ 160:997-1002, 1999
10. Chamberland ME: Emerging infectious agents: Do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis 34:797-805, 2002
11. Coulthart MB, Cashman NR: Variant Creutzfeldt-Jakob disease: A summary of current scientific knowledge in relation to public health. Can Med Assoc J 165:51-58, 2001
12. Popovsky MA: Transfusion-related acute lung injury. Curr Opin Hematol 7:402-407, 2000
13. Williamson LM, Lowe S, Love EM, et al: Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports. BMJ 319:16-19, 1999
14. Vamvakas EC, Pineda AA: Autologous transfusion and other approaches to reduce allogeneic blood exposure. Best Pract Res Clin Haematol 13:533-547, 2000
15. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction? Blood 97:1180-1195, 2001
16. Duffy G, Neal KR: Differences in postoperative infection rates between patients receiving autologous and allogeneic blood transfusion: A meta-analysis of published randomized and nonrandomized studies. Transfus Med 6:325-328, 1996
17. Vanderlinde ES, Heal JM, Blumberg N: Autologous transfusion. BMJ 324:772-775, 2002
18. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP: Transfusion medicine: I. blood transfusion. N Engl J Med 340:438-447, 1999
19. Lee SJ, Liljas B, Churchill WH, et al.: Perceptions and preferences of autologous blood donors. Transfusion 38:757-763, 1998
20. Popovsky MA, Whitaker B, Arnold NL: Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 35:734-737, 1995
21. Kasper SM, Ellering J, Stachwitz P, et al: All adverse events in autologous blood donors with cardiac disease are not necessarily caused by blood donation. Transfusion 38:669-673, 1998
22. AuBuchon JP, Popovsky MA: The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion 31:513-517, 1991
23. Petitti DB: Meta-analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. New York, Oxford University Press, 1994
24. Forbes JM, Anderson MD, Anderson GF, et al: Blood transfusion costs: A multicenter study. Transfusion 31:318-323, 1991
25. Tretiak R, Laupacis A, Riviere M, et al: Cost of allogeneic and autologous blood transfusion in Canada. Can Med Assoc J 154:1501-1508, 1996
26. Renner SW, Howanitz PJ, Bachner P: Preoperative autologous blood donation in 612 hospitals. A College of American Pathologists' Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med 116:613-619, 1992
27. Karkouti K, Cohen MM, McCluskey SA, et al: A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass grafting. Transfusion 41:1193-1203, 2001
28. Jefferson T, Demicheli V: Quality of economic evaluations in health care. BMJ 324:313-314, 2002
29. Kassirer JP, Angell M: The Journal's policy on cost-effectiveness analyses. N Engl J Med 331:669-670, 1994
30. Fergusson D, van Walraven C, Coyle D, Laupacis A: Economic evaluations of technologies to minimize perioperative transfusion: A systematic review of published studies. Transfus Med Rev 13:106-117, 1999
31. Elawad A, Benoni G, Montgomery F, et al: Cost-effectiveness of blood substitution in elective orthopedic operations. Acta Orthop Scand 62:435-439, 1991
32. Healy JC, Frankforter SA, Graves BK, et al: Preoperative autologous blood donation in total-hip arthroplasty: A cost-effectiveness analysis. Arch Pathol Lab Med 118:465-470, 1994
33. Blumberg N, Kirkey SA, Heal JM: A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Am J Surg 171:324-330, 1996
34. Roberts WA, Kirkley SA, Newby M: A cost comparison of allogeneic and preoperatively or intraoperatively donated autologous blood. Anesth Analg 83:129-133, 1996
35. Sonnenberg FA, Gregory P, Yomtovian R, et al: The cost-effectiveness of autologous transfusion revisited: Implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion 39:808-817, 1999